- Record: found
- Abstract: not found
- Article: not found
Initial results of a phase 1 dose expansion cohort of M6620 (formerly VX-970), an ATR inhibitor, in combination with cisplatin in patients with advanced triple-negative breast cancer NCT02157792)
M.L. Telli, S Lord, E DEAN, V. Abramson, H-T Arkenau, C Becerra, S.M. Tolaney, R TANG, M.S. Penney, J Pollard, S. LORD, G Conboy, S.Z Fields, G Shapiro, E Dean, C BECERRA, R Tang
2017
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.